- Home
- DRTS vs ELVR Comparison
DRTS vs ELVR Comparison
Compare DRTS & ELVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRTS
- ELVR
- Stock Information
- Founded
- DRTS 2015
- ELVR N/A
- Country
- DRTS Israel
- ELVR Australia
- Employees
- DRTS N/A
- ELVR N/A
- Industry
- DRTS Medical/Dental Instruments
- ELVR Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- DRTS Health Care
- ELVR Industrials
- Exchange
- DRTS Nasdaq
- ELVR Nasdaq
- Market Cap
- DRTS 300.2M
- ELVR 254.1M
- IPO Year
- DRTS N/A
- ELVR N/A
- Fundamental
- Price
- DRTS $3.91
- ELVR $17.66
- Analyst Decision
- DRTS Strong Buy
- ELVR
- Analyst Count
- DRTS 1
- ELVR 0
- Target Price
- DRTS $9.00
- ELVR N/A
- AVG Volume (30 Days)
- DRTS 64.0K
- ELVR N/A
- Earning Date
- DRTS 08-11-2025
- ELVR N/A
- Dividend Yield
- DRTS N/A
- ELVR N/A
- EPS Growth
- DRTS N/A
- ELVR N/A
- EPS
- DRTS N/A
- ELVR N/A
- Revenue
- DRTS N/A
- ELVR N/A
- Revenue This Year
- DRTS N/A
- ELVR N/A
- Revenue Next Year
- DRTS N/A
- ELVR N/A
- P/E Ratio
- DRTS N/A
- ELVR N/A
- Revenue Growth
- DRTS N/A
- ELVR N/A
- 52 Week Low
- DRTS $2.11
- ELVR N/A
- 52 Week High
- DRTS $4.39
- ELVR N/A
- Technical
- Relative Strength Index (RSI)
- DRTS 54.16
- ELVR N/A
- Support Level
- DRTS N/A
- ELVR N/A
- Resistance Level
- DRTS $3.99
- ELVR N/A
- Average True Range (ATR)
- DRTS 0.16
- ELVR 0.00
- MACD
- DRTS -0.11
- ELVR 0.00
- Stochastic Oscillator
- DRTS 97.99
- ELVR 0.00
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.